Adults with obesity (BMI ≥30) or with overweight (BMI ≥27) plus at least one weight-related condition such as type 2 diabetes, hypertension or dyslipidaemia.
- Once-weekly self-injection in the thigh, abdomen or upper arm.
- Dose is escalated gradually (0.25 mg → 0.5 → 1.0 → 1.7 → 2.4 mg) over 16 weeks to limit gastrointestinal side effects.
- Combined with diet and physical activity — semaglutide is not a substitute for lifestyle change.
- Severe abdominal pain radiating to the back (possible pancreatitis) — stop the medicine and seek urgent care.
- Gallbladder problems — sudden right-upper abdominal pain, jaundice, fever.
- Sudden vision changes in patients with type 2 diabetic retinopathy — see an ophthalmologist promptly.
- Signs of severe dehydration from prolonged vomiting / diarrhoea — risk of acute kidney injury.
- Severe allergic reaction (rash, swelling, breathlessness).
WHEN TO CALL THE DOCTOR
Call us through the in-app chat if you notice…
- Severe or persistent vomiting, dehydration, or inability to eat for more than 48h.
- New, severe abdominal pain that doesn't ease — A&E first.
- Pregnancy or a positive pregnancy test — stop the medicine immediately.
- A new medication or condition since your last consultation.
OFFICIAL SOURCE
This summary is condensed from the regulator's full product leaflet for ease of reading. The complete document — every interaction, dose adjustment and reporting note — is one click away.
This page summarises information from the regulator-approved leaflet for reference only. It is not medical advice and does not replace the assessment of an EU-licensed doctor. Your doctor will review your individual history, dose and interactions during your consultation.
← Back to consultationYou can print this page for your records.